Author:
Isaranuwatchai Wanrudee,de Oliveira Claire,Mittmann Nicole,Evans William K (Bill),Peter Alice,Truscott Rebecca,Chan Kelvin KW
Abstract
ObjectiveSmoking is the main modifiable cancer risk factor. The objective of this study was to examine the impact of smoking on health system costs among newly diagnosed adult patients with cancer. Specifically, costs of patients with cancer who were current smokers were compared with those of non-smokers from a publicly funded health system perspective.MethodsThis population-based cohort study of patients with cancer used administrative databases to identify smokers and non-smokers (1 April 2014–31 March 2016) and their healthcare costs in the 12–24 months following a cancer diagnosis. The health services included were hospitalisations, emergency room visits, drugs, home care services and physician services (from the time of diagnosis onwards). The difference in cost (ie, incremental cost) between patients with cancer who were smokers and those who were non-smokers was estimated using a generalised linear model (with log link and gamma distribution), and adjusted for age, sex, neighbourhood income, rurality, cancer site, cancer stage, geographical region and comorbidities.ResultsThis study identified 3606 smokers and 14 911 non-smokers. Smokers were significantly younger (61 vs 65 years), more likely to be male (53%), lived in poorer neighbourhoods, had more advanced cancer stage,and were more likely to die within 1 year of diagnosis, compared with non-smokers. The regression model revealed that, on average, smokers had significantly higher monthly healthcare costs ($5091) than non-smokers ($4847), p<0.05.ConclusionsSmoking status has a significant impact on healthcare costs among patients with cancer. On average, smokers incurred higher healthcare costs than non-smokers. These findings provide a further rationale for efforts to introduce evidence-based smoking cessation programmes as a standard of care for patients with cancer as they have the potential not only to improve patients’ outcomes but also to reduce the economic burden of smoking on the healthcare system.
Funder
Centre for Applied Research in Cancer Control
Reference37 articles.
1. The High Cost of Prescription Drugs in the United States
2. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study
3. Canadian Cancer Society. Nearly 1 in 2 Canadians expected to get cancer: report. 2017 http://www.cancer.ca/en/about-us/for-media/media-releases/national/2017/canadian-cancer-statistics/?region=bc.
4. The economic burden of cancer care in Canada: a population-based cost study;de Oliveira;CMAJ Open,2018
5. Cancer Care Ontario. Cancer Risk Factors in Ontario: Tobacco. 2014.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献